Key result
A systematic review of epistaxis management strategies found limited evidence overall, with level 1 evidence supporting only the use of tranexamic acid.
Why the study?
What is the evidence supporting epistaxis-specific management strategies relating to haematological factors in adults?
Systematic Review
What is the evidence supporting epistaxis-specific management strategies relating to haematological factors in adults?
There is a lack of specific evidence for managing haematological factors in epistaxis, suggesting that general national guidance for major bleeding and transfusion should be applied.
Haematological epistaxis management should follow general major bleeding guidelines; systematic review leaves open dedicated strategies.
BACKGROUND: The management of epistaxis requires an understanding of haematological factors that may complicate its treatment. This systematic review includes six distinct reviews examining the evidence supporting epistaxis-specific management strategies relating to warfarin, direct oral anticoagulants, heparin, antiplatelet agents, tranexamic acid and transfusion. METHOD: A systematic review of the literature was performed using a standardised methodology and search strategy. RESULTS: Limited numbers of articles were identified in each systematic review, with level 1 evidence only regarding the use of tranexamic acid. No studies met the inclusion criteria within the heparin, direct oral anticoagulants or transfusion systematic reviews. Many studies were limited by small sample sizes and significant risk of bias. CONCLUSION: The management of major bleeding and transfusion practice is well documented in national guidance from multiple sources. The guidelines include advice on anticoagulants, antiplatelet agents and tranexamic acid. In the absence of more specific evidence, these guidelines should be applied in the management of epistaxis.
No takes yet. Share an insight, caveat, or question.
Williams et al. (2017) conducted a systematic review in Adult epistaxis. Management strategies relating to warfarin, direct oral anticoagulants, heparin, antiplatelet agents, tranexamic acid and transfusion was evaluated. A systematic review of epistaxis management strategies found limited evidence overall, with level 1 evidence supporting only the use of tranexamic acid.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: